Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Sampath

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Blood|October 21, 2016
Targeting BTK through microRNA in chronic lymphocytic leukemiaArianna Bottoni, Lara Rizzotto, Tzung-Huei Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2022
Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation TherapyJihong Xu, Pei-Jung Wu, Tzung-Huei Lai, et al.
Cancer Research|September 14, 2018
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced CachexiaFederica Calore, Priya Londhe, Paolo Fadda, et al.
Blood|April 2, 2020
Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutationsFabienne Lucas, Karylin Larkin, C Thomas Gregory, et al.
Oncotarget|April 17, 2017
The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemiaCecelia R Miller, Amy S Ruppert, Sydney Fobare, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2019
Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell LymphomaFabienne Lucas, Kerry A Rogers, Bonnie K Harrington, et al.
Science Advances|September 16, 2022
Targeting OXPHOS de novo purine synthesis as the nexus of <i>FLT3</i> inhibitor-mediated synergistic antileukemic actionsPu Zhang, Lindsey T Brinton, Mehdi Gharghabi, et al.
Blood|April 16, 2010
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survivalSimona Rossi, Masayoshi Shimizu, Elisa Barbarotto, et al.
Leukemia|November 14, 2022
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemiaSteven Sher, Ethan Whipp, Janek Walker, et al.
Cancer Discovery|August 11, 2018
The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter TransformationSean D Reiff, Rose Mantel, Lisa L Smith, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Blood|October 21, 2016
Targeting BTK through microRNA in chronic lymphocytic leukemiaArianna Bottoni, Lara Rizzotto, Tzung-Huei Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2022
Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation TherapyJihong Xu, Pei-Jung Wu, Tzung-Huei Lai, et al.
Cancer Research|September 14, 2018
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced CachexiaFederica Calore, Priya Londhe, Paolo Fadda, et al.
Blood|April 2, 2020
Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutationsFabienne Lucas, Karylin Larkin, C Thomas Gregory, et al.
Oncotarget|April 17, 2017
The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemiaCecelia R Miller, Amy S Ruppert, Sydney Fobare, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2019
Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell LymphomaFabienne Lucas, Kerry A Rogers, Bonnie K Harrington, et al.
Science Advances|September 16, 2022
Targeting OXPHOS de novo purine synthesis as the nexus of <i>FLT3</i> inhibitor-mediated synergistic antileukemic actionsPu Zhang, Lindsey T Brinton, Mehdi Gharghabi, et al.
Blood|April 16, 2010
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survivalSimona Rossi, Masayoshi Shimizu, Elisa Barbarotto, et al.
Leukemia|November 14, 2022
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemiaSteven Sher, Ethan Whipp, Janek Walker, et al.
Cancer Discovery|August 11, 2018
The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter TransformationSean D Reiff, Rose Mantel, Lisa L Smith, et al.
Pageof 6